Search - tctmd.com

Displaying 441 - 460 of 587

Sort: Relevancy | Date

Presentation TCT 2012

Debate: Yes to Routine Thrombectomy in STEMI: New Trials Are Not Needed!

Presenter: Giuseppe De Luca

October 25, 2012

Presentation TCT 2012

Debate: Transradial Access Should Be the Default Access Site in STEMI Patients!

Presenter: Jennifer Tremmel

October 25, 2012

Presentation TCT 2012

Debate: Transfemoral Access Should Be the Default Access Site in STEMI Patients!

Presenter: Michael Haude

October 25, 2012

Presentation TCT 2012

Debate: Primary PCI Is the Default Reperfusion Method Irrespective of Time to Transfer!

Presenter: Cindy Grines

October 25, 2012

Presentation TCT 2012

Debate: No to Routine Thrombectomy in STEMI: Still Yet to Be Demonstrated!

Presenter: Sanjit Jolly

October 25, 2012

$Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!$

Presentation TCT 2012

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Gilles Montalescot

October 25, 2012

Presentation TCT 2012

Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Roxana Mehran

October 25, 2012

Presentation TCT 2012

A Prospective, Randomized Trial of Post-Conditioning in Patients with ST-Segment Elevation Myocardial Infarction

Presenter: Joo-Yong Hahn

October 25, 2012

Presentation TCT 2012

Variations in the Management of ACS in South America: A Viewpoint from South of the Border

Presenter: Alexandre Abizaid

October 25, 2012

Presentation TCT 2012

Variations in Management of ACS in Europe: Implications for Health Care Reform in the United States

Presenter: Christian Hamm

October 25, 2012

Presentation TCT 2012

Part 2: Antiplatelet Agents

Presenter: Robert Harrington

October 25, 2012

Presentation TCT 2012

Part 1: Oral Anticoagulants

Presenter: Christopher Granger

October 25, 2012

Presentation TCT 2012

Novel Anticoagulants in Patients with Acute Coronary Syndromes

Presenter: C. Michael Gibson

October 25, 2012

Presentation TCT 2012

To Stage or Not to Stage?

Presenter: Philippe Genereux

October 24, 2012

Presentation TCT 2012

The Potential of Otamixaban as a Procedural Anticoagulant

Presenter: Philippe Steg

October 24, 2012

Presentation TCT 2012

Systemic Hypothermia: For Hospital Arrest and Myocardial Infarction?

Presenter: Goran Olivecrona

October 24, 2012

Presentation TCT 2012

STEMI Cocktails

Presenter: Shamir Mehta

October 24, 2012

Presentation TCT 2012

Should P2Y12 Antagonists Be Continued Through CABG in Patients with ACS?

Presenter: Adnan Kastrati

October 24, 2012

Presentation TCT 2012

Should All Patients with STEMI Be Transferred to a PCI-Capable Hospital?

Presenter: Jacqueline Tamis-Holland

October 24, 2012

Presentation TCT 2012

Pro!(5)

Presenter: Matthew Price

October 24, 2012

Advertisement

Debate: Yes to Routine Thrombectomy in STEMI: New Trials Are Not Needed!

Debate: Transradial Access Should Be the Default Access Site in STEMI Patients!

Debate: Transfemoral Access Should Be the Default Access Site in STEMI Patients!

Debate: Primary PCI Is the Default Reperfusion Method Irrespective of Time to Transfer!

Debate: No to Routine Thrombectomy in STEMI: Still Yet to Be Demonstrated!

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!

A Prospective, Randomized Trial of Post-Conditioning in Patients with ST-Segment Elevation Myocardial Infarction

Variations in the Management of ACS in South America: A Viewpoint from South of the Border

Variations in Management of ACS in Europe: Implications for Health Care Reform in the United States

Part 2: Antiplatelet Agents

Part 1: Oral Anticoagulants

Novel Anticoagulants in Patients with Acute Coronary Syndromes

To Stage or Not to Stage?

The Potential of Otamixaban as a Procedural Anticoagulant

Systemic Hypothermia: For Hospital Arrest and Myocardial Infarction?

STEMI Cocktails

Should P2Y12 Antagonists Be Continued Through CABG in Patients with ACS?

Should All Patients with STEMI Be Transferred to a PCI-Capable Hospital?

Pro!(5)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content